neurofibroma (Cancer)
Information
- Disease name
- neurofibroma
- Disease ID
- DOID:962
- Description
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| NF1 | 17 | 31,094,977 | 31,377,675 | 2 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03820778 | Active, not recruiting | N/A | Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 | July 12, 2018 | August 1, 2022 |
| NCT00924196 | Active, not recruiting | Natural History Study of Patients With Neurofibromatosis Type I | February 25, 2008 | ||
| NCT00314119 | Completed | Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1 | June 8, 2006 | ||
| NCT01031901 | Completed | Phase 1 | Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) | December 2009 | June 2011 |
| NCT01347307 | Completed | N/A | Stereotactic Body Radiotherapy for Spine Tumors | September 2008 | September 2017 |
| NCT06322342 | Recruiting | Phase 2 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | March 15, 2024 | March 2025 |
| NCT05199376 | Recruiting | N/A | Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1 | February 14, 2022 | February 7, 2027 |
| NCT05891847 | Recruiting | Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia | March 21, 2023 | March 20, 2026 | |
| NCT00716469 | Terminated | Phase 1 | Phase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neurofibromas | July 2008 | July 2012 |
| NCT01567787 | Withdrawn | N/A | Proton Radiation Therapy for Spinal Tumors | June 2013 | August 2015 |
- Disase is a (Disease Ontology)
- DOID:3193
- Cross Reference ID (Disease Ontology)
- GARD:7191
- Cross Reference ID (Disease Ontology)
- ICDO:9540/0
- Cross Reference ID (Disease Ontology)
- MESH:D009455
- Cross Reference ID (Disease Ontology)
- NCI:C3272
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:404029005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0027830
- MeSH unique ID (MeSH (Medical Subject Headings))
- D009455